Cognitive disorders in patients with neuroimmunological disease
- 24 January 2025
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Psychiatry
- Vol. 38 (2) , 126-133
Abstract
Purpose of review: Autoimmune diseases such as systemic lupus erythematosus (SLE), multiple sclerosis (MS), and autoimmune encephalitis can directly and indirectly affect brain function, leading to cognitive dysfunction or well characterized neurocognitive syndromes. However, these are often poorly characterized in the literature. Here, we review evidence on clinical manifestations, risk factors, their assessment and outcomes, and evidence for underlying mechanisms and associated biomarkers, if available. Recent findings: Significant advances have been made in neurocognitive disorders associated with four categories of autoimmune disease: neurocognitive disorders due to autoimmune connective tissue diseases, neurocognitive disorders due to autoimmune demyelinating diseases of the CNS, neurocognitive disorders due to autoimmune encephalitis, and neurocognitive disorders due to cerebrovascular disease of autoimmune origin. Summary: Autoimmune diseases should be considered as critical causal factors underlying new cases of neurocognitive disorder, especially in young patients. These diseases are mediated by immune system reactions involving antibody production, T-cell-mediated damage, and demyelination. Although the prognosis seems favourable in most conditions after immunotherapy, the magnitude of the therapeutic effect of immunotherapy on cognitive functioning remains unclear.Keywords
This publication has 51 references indexed in Scilit:
- Systemic Lupus ErythematosusJAMA, 2024
- Domain‐specific cognitive impairment in multiple sclerosis: A systematic review and meta‐analysisAnnals of Clinical and Translational Neurology, 2024
- Cognitive phenotypes in multiple sclerosis: mapping the spectrum of impairmentJournal of Neurology, 2023
- Primary angiitis of the CNS and ANCA-associated vasculitis: from pathology to treatmentRheumatology International, 2023
- High Prevalence but Low Impact of Cognitive Dysfunction on Quality of Life in Patients With Lupus and Neuropsychiatric SymptomsArthritis Care & Research, 2022
- Long‐Term Cognitive Outcome in Anti–N‐Methyl‐D‐Aspartate Receptor EncephalitisAnnals of Neurology, 2021
- Cognitive Function Trajectories in Association With the Depressive Symptoms Trajectories in Systemic Lupus Erythematosus Over TimeArthritis Care & Research, 2021
- Correction to: “When should primary angiitis of the central nervous system (PACNS) be suspected?”: literature review and proposal of a preliminary screening algorithmNeurological Sciences, 2020
- Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugsClinical Rheumatology, 2020
- Cognitive dysfunction and brain atrophy in Susac syndromeJournal of Neurology, 2019